About Arterial Dynamics
Arterial Dynamics is an early-stage biotechnology and medical device firm committed to revolutionizing fluid processing for critical medicine.
By rethinking how fluid dynamics interact with delicate cell populations, we develop single-use microfluidic systems that protect cell viability, streamline clinical workflows, and expand access to life-saving cellular therapies.
Our Mission
To replace high-shear mechanical separation and chemical labeling with precise, non-destructive fluid dynamic tools—enabling safer therapeutic apheresis, faster biomanufacturing, and superior diagnostic accuracy.
Institutional & Research Foundation
Operated out of research facilities in Golden, Colorado, Arterial Dynamics combines decades of expertise in fluid mechanics, scientific prototyping, and physical analysis.
Our development pipeline actively engages federal grant frameworks, clinical research partners, and formal regulatory feedback channels—including the FDA Pre-Submission (Q-Sub) program—to transition microfluidic separation from concept to bedside.
Contact Information
Entity: Arterial Dynamics LLC
Location: Golden, Colorado, USA
Inquiries: [email protected]
About Arterial Dynamics
★★★★★
At Arterial Dynamics, we are dedicated to revolutionizing the treatment of blood diseases through innovative medical devices. Our flagship technology, the Medical Entropy Pump, is grounded in advanced research from the University of Alabama, utilizing Lorentz Force Ion Polarization to enhance patient outcomes. We focus on conditions such as Leukemia, Sickle Cell Diseases, and Atherosclerosis, aiming to provide effective solutions that improve the quality of life for patients. Our commitment to excellence drives us to seek investment and development opportunities to further advance our groundbreaking technology. Join us in our mission to transform healthcare and make a significant impact in the medical field.
Advantages
+ Innovative technology based on advanced research
+ Targeted solutions for specific blood diseases
+ Potential for significant patient outcome improvements
Challenges
– Arterial Dynamics seeks to simplify the Medical Entropy Pump to allow for widespread deployment.
– We seek to engineer simple and effective systems to integrate into existing medical processes for leukemia and sickle cell treatment.
Technical Details
Even with contempaorary advancements in the treatment of blood diseases and cancers, patients often experience discomfort and negative outcome due to misshapen white and red blood cells. White blood cells without proper surface tension increase blood viscosity and thus decrease oxygen and nutrient transport, which can leave the patient weak and unable to tolerate cancer and chronic treatments. Similarly, misshapen sickle-shaped red blood cells can obstruct blood flow in capillaries and organs leading to a sickle crisis, or rupture into blood plasma.
Extracorporeal Blood Treatment
Arterial Dynamics has developed foundational extracorporeal treatments based on carefully-modulated fluid dynamics from our peer-reveiwed and tested Entropy Pump technology. Using a treatment path similar to dialysis, misshapen blood cells are separated from healthy blood cells and shunted out of the plasma. Healthy blood returns to the patient. Treatment is administered as needed for patient comfort and outcome.
Medical Entropy Pump versus Dialysis
The blood flow and management systems are similar, but while dialysis uses an osmosis system to separate waste and water from blood, the medical entropy pump uses fluid dynamics to separate misshapen cells from healthy cells and blood plasma.
Current Work
Foundational research in Lorentz Force Ion Polarization has been completed, demonstrated, peer-reviewed and published at University of Alabama. Work has continued from there in the medical entropy pump, which is the underlying physical engine that delivers patient treatment. This work is currently in the next phase of development in our small lab in Golden, Colorado.
The People behind the scene
Meet our team
Ehud Lissauer
CEO
Passion and commitment to build meaningful relationships and impact the world with purpose. Ehud has led financial operations and sales with organizations including CT Group, AIG Financial, OpVest, and CAE Managment. Ehud has built capital investment under strict regulatory oversight with Series 7, Series 3, and Series 66 licensing. He received his Bachelor’s Degree in Psychology from University of Colorado, Boulder.
Mike Wofsey
Prinicipal Researcher
Research Physicist in low-energy medical radiotherapy. Focus on affordable and accessible medical technologies. Mike has worked in applied physics and communications for organizations including Dow Jones, U.S. Department of Energy, McGraw Hill, Australian Provincial Newspapers, and Scientific Illustration Services. He received his Ph.D. in applied physics from University of Alabama, and his MA in physics from City University of New York.
Sedra Fredrick
Comptroller
Sedra brings over 25 years of financial management experience to Arterial Dynamics, with financial operations oversight experience for clients including Keybank, Public Service Credit Union, Wells Fargo Bank, Stravolo Wealth Management, Dana F. Cole & Co,, Appliance Factory and ML Distribution. Sedra received Signature Circle recognition, and received her financial training from Ashford University. Sedra volunteers community service with Ronald McDonald House, YWCA and Community Works.